Elfasi, A., Goldman, M. D., Riley, C., Zamvil, S. S., & Newsome, S. D. (2025). “Will the Real Demyelinating Disorder Please Stand Up?” Neurology Neuroimmunology & Neuroinflammation, 12(3). https://doi.org/10.1212/nxi.0000000000200380

Krett, J. D., Riley, C., Zamvil, S. S., Goldman, M. D., Newsome, S. D., & Saidha, S. (2025). Mood Disorder and Multimorbidity Complicating a Multiple Sclerosis Diagnosis. Neurology Neuroimmunology & Neuroinflammation, 12(2). https://doi.org/10.1212/nxi.0000000000200376

Simani, L., Tozlu, C., Lee, S., Dworkin, J., Ratzan, A. S., Buyukturkoglu, K., Onomichi, K., Mata, J., Riley, C. S., & Leavitt, V. M. (2025). Longitudinal investigation of neuroimaging changes related to memory decline in multiple sclerosis: Testing a mechanistic model. Multiple Sclerosis Journal, 31(2), 207–217. https://doi.org/10.1177/13524585241303491

Kever, A., Heuer, L. B., Simani, L., & Leavitt, V. M. (2024). Development and initial validation of the Cognitive Change Scale (CCS). Multiple Sclerosis Journal, 30(14), 1815–1824. https://doi.org/10.1177/13524585241290102

Simani, L., Molaeipour, L., Kian, S., & Leavitt, V. M. (2024). Correlation between cognitive changes and neuroradiological changes over time in multiple sclerosis: a systematic review and meta-analysis. Journal of Neurology, 271(8), 5498–5518. https://doi.org/10.1007/s00415-024-12517-8

Leavitt, V. M., Bae, C., Shinohara, R. T., Weinstein, S. M., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2024). Diagnosis concealment behaviors and disclosure beliefs are associated with health and quality of life in people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105628. https://doi.org/10.1016/j.msard.2024.105628

Leavitt, V. M., Dworkin, J. D., Kalina, T., & Ratzan, A. S. (2024). Sex differences in brain resilience of individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders, 87, 105646. https://doi.org/10.1016/j.msard.2024.105646

Leavitt, V. M. (2024). Depression is a core symptom of multiple sclerosis: No. Multiple Sclerosis Journal, 30(7), 787–788. https://doi.org/10.1177/13524585241245653

Lalle, G., Lautraite, R., Bouherrou, K., Plaschka, M., Pignata, A., Voisin, A., Twardowski, J., Perrin-Niquet, M., Stéphan, P., Durget, S., Tonon, L., Ardin, M., Degletagne, C., Viari, A., Belgarbi Dutron, L., Davoust, N., Postler, T. S., Zhao, J., Caux, C., … Grinberg-Bleyer, Y. (2024). NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer. Journal of Experimental Medicine, 221(6). https://doi.org/10.1084/jem.20231348

Leavitt, V. M., Dworkin, J. D., Galioto, R., & Ratzan, A. S. (2024). Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders, 85, 105508. https://doi.org/10.1016/j.msard.2024.105508

Cote, S. E., Wagshul, M., Foley, F. W., Picone, M. A., Lipton, M., Lee, J. S., & Holtzer, R. (2024). Frontal-striatal tract integrity and depression in older adults with and without multiple sclerosis. Neurological Sciences, 45(7), 3359–3368. https://doi.org/10.1007/s10072-024-07316-y

Radzik, A. M., Amezcua, L., Anderson, A., Gilmore, S., Ahmad, S., Brandstadter, R., Fabian, M. T., Graham, E. L., Hodgkinson, S., Horton, L., Jacobs, D. A., Katz Sand, I. B., Kohli, A., Levine, L., McLemore, M., Okai, A. F., Patel, J., Poole, S., Riley, C., … Bove, R. (2024). Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis. Neurology, 102(4). https://doi.org/10.1212/wnl.0000000000208100

Riley, C., Venkatesh, S., Dhand, A., Doshi, N., Kavak, K., Levit, E., Perrone, C., Weinstock-Guttman, B., Longbrake, E., De Jager, P., & Xia, Z. (2024). Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study. JMIR Public Health and Surveillance, 10, e45429. https://doi.org/10.2196/45429

Motl, R. W., Foley, F. W., Picone, M. A., Lipton, M. L., Izzetoglu, M., Hernandez, M. E., & Holtzer, R. (2024). Initial validation of the university of Alabama Birmingham study of aging life-space assessment in older adults with multiple sclerosis. Multiple Sclerosis and Related Disorders, 82, 105354. https://doi.org/10.1016/j.msard.2023.105354

Ramanathan, U., Besbris, J. M., Kramer, N. M., Yu, A. W., Solomon, A. J., Jones, C. A., & Mehta, A. K. (2023). Top Ten Tips Palliative Care Clinicians Should Know about Multiple Sclerosis. Journal of Palliative Medicine, 26(11), 1555–1561. https://doi.org/10.1089/jpm.2023.0179

Kaplan, J., Askanase, A., Chu, D., Abdellatif, A., Basu, D., & Mirsaeidi, M. (2023). Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence. Clinical Drug Investigation, 43(10), 739–761. https://doi.org/10.1007/s40261-023-01303-5

Anderson, J. R., Fitzgerald, K. C., Murrough, J. W., Katz Sand, I. B., Sorets, T. R., Krieger, S. C., Riley, C. S., Fabian, M. T., & Sumowski, J. F. (2023). Depression symptoms and cognition in multiple sclerosis: Longitudinal evidence of a specific link to executive control. Multiple Sclerosis Journal, 29(13), 1632–1645. https://doi.org/10.1177/13524585231198746

Juchem, C., Swanberg, K. M., Prinsen, H., & Pelletier, D. (2023). In vivo cortical glutathione response to oral fumarate therapy in relapsing-remitting multiple sclerosis: A single-arm open-label phase IV trial using 7-Tesla 1H MRS. NeuroImage: Clinical, 39, 103495. https://doi.org/10.1016/j.nicl.2023.103495

Anderson, A., Rowles, W., Poole, S., Balan, A., Bevan, C., Brandstadter, R., Ciplea, A. I., Cooper, J., Fabian, M., Hale, T. W., Jacobs, D., Kakara, M., Krysko, K. M., Longbrake, E. E., Marcus, J., Repovic, P., Riley, C. S., Romeo, A. R., Rutatangwa, A., … Bove, R. (2023). Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Annals of Clinical and Translational Neurology, 10(11), 2053–2064. Portico. https://doi.org/10.1002/acn3.51893

Cote, S. E., Wagshul, M. E., Foley, F. W., Lipton, M. L., & Holtzer, R. (2023). Caudate volume and symptoms of apathy in older adults with multiple sclerosis. Multiple Sclerosis Journal, 29(10), 1266–1274. https://doi.org/10.1177/13524585231188096

Klineova, S., Farber, R. S., DeAngelis, T., Leung, T., Smith, T., Blanck, R., Zhovtis-Ryerson, L., & Harel, A. (2023). Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2). Multiple Sclerosis Journal, 29(8), 990–1000. https://doi.org/10.1177/13524585231185246

Shafit-Zagardo, B., Sidoli, S., Goldman, J. E., DuBois, J. C., Corboy, J. R., Strittmatter, S. M., Guzik, H., Edema, U., Arackal, A. G., Botbol, Y. M., Merheb, E., Nagra, R. M., & Graff, S. (2023). TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury. Cells, 12(13), 1734. https://doi.org/10.3390/cells12131734

Okuda, D. T., Kantarci, O., Lebrun‐Frénay, C., Sormani, M. P., Azevedo, C. J., Bovis, F., Hua, L. H., Amezcua, L., Mowry, E. M., Hotermans, C., Mendoza, J., Walsh, J. S., von Hehn, C., Vargas, W. S., Donlon, S., Naismith, R. T., Okai, A., Pardo, G., Repovic, P., … Pelletier, D. (2022). Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Annals of Neurology, 93(3), 604–614. Portico. https://doi.org/10.1002/ana.26555

Beecham, A. H., Amezcua, L., Chinea, A., Manrique, C. P., Gomez, L., Martinez, A., Beecham, G. W., Patsopoulos, N. A., Chitnis, T., Weiner, H. L., De Jager, P. L., Burchard, E. G., Lund, B. T., Fitzgerald, K. C., Calabresi, P. A., Delgado, S. R., Oksenberg, J. R., & McCauley, J. L. (2022). Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population. PLOS ONE, 17(12), e0279132. https://doi.org/10.1371/journal.pone.0279132

Petracca, M., Palladino, R., Droby, A., Kurz, D., Graziano, N., Wang, K., Riley, C., Howard, J., Klineova, S., Lublin, F., & Inglese, M. (2023). Disability outcomes in early-stage African American and White people with multiple sclerosis. Multiple Sclerosis and Related Disorders, 69, 104413. https://doi.org/10.1016/j.msard.2022.104413

Esposito, F., Osiceanu, A. M., Sorosina, M., Ottoboni, L., Bollman, B., Santoro, S., Bettegazzi, B., Zauli, A., Clarelli, F., Mascia, E., Calabria, A., Zacchetti, D., Capra, R., Ferrari, M., Provero, P., Lazarevic, D., Cittaro, D., Carrera, P., Patsopoulos, N., … Martinelli Boneschi, F. (2022). A Whole-Genome Sequencing Study Implicates GRAMD1B in Multiple Sclerosis Susceptibility. Genes, 13(12), 2392. https://doi.org/10.3390/genes13122392

Ed‐driouch, C., Chéneau, F., Simon, F., Pasquier, G., Combès, B., Kerbrat, A., Le Page, E., Limou, S., Vince, N., Laplaud, D., Mars, F., Dumas, C., Edan, G., & Gourraud, P. (2022). Multiple sclerosis clinical decision support system based on projection to reference datasets. Annals of Clinical and Translational Neurology, 9(12), 1863–1873. Portico. https://doi.org/10.1002/acn3.51649

Buyukturkoglu, K., Dworkin, J. D., Leiva, V., Provenzano, F. A., Guevara, P., De Jager, P. L., Leavitt, V. M., & Riley, C. S. (2022). Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis. Multiple Sclerosis and Related Disorders, 68, 104247. https://doi.org/10.1016/j.msard.2022.104247

Leavitt, V. M., Kever, A. M., Weinstein, S. M., Shinohara, R. T., Schmidt, H., Aoun, S. M., Solari, A., & Solomon, A. J. (2022). Diagnosis concealment is prevalent in MS, and associated with diagnosis experience. Multiple Sclerosis and Related Disorders, 68, 104373. https://doi.org/10.1016/j.msard.2022.104373

Swanberg, K. M., Kurada, A. V., Prinsen, H., & Juchem, C. (2022). Multiple sclerosis diagnosis and phenotype identification by multivariate classification of in vivo frontal cortex metabolite profiles. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-17741-8

Ostkamp, P., Deffner, M., Schulte-Mecklenbeck, A., Wünsch, C., Lu, I.-N., Wu, G. F., Goelz, S., De Jager, P. L., Kuhlmann, T., Gross, C. C., Klotz, L., Meyer zu Hörste, G., Wiendl, H., Schneider-Hohendorf, T., & Schwab, N. (2022). A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis. Science Translational Medicine, 14(673). https://doi.org/10.1126/scitranslmed.adc9778

Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., Saab, G., & Shah, P. (2022). Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3. Neurology Neuroimmunology & Neuroinflammation, 9(6). https://doi.org/10.1212/nxi.0000000000200032

Pitt, D., Lo, C. H., Gauthier, S. A., Hickman, R. A., Longbrake, E., Airas, L. M., Mao-Draayer, Y., Riley, C., De Jager, P. L., Wesley, S., Boster, A., Topalli, I., Bagnato, F., Mansoor, M., Stuve, O., Kister, I., Pelletier, D., Stathopoulos, P., Dutta, R., & Lincoln, M. R. (2022). Toward Precision Phenotyping of Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation, 9(6). https://doi.org/10.1212/nxi.0000000000200025

Leavitt, V. M., Dworkin, J. D., Buyukturkoglu, K., Riley, C. S., & Ritchey, M. (2022). Summary metrics of memory subnetwork functional connectivity alterations in multiple sclerosis. Multiple Sclerosis Journal, 28(12), 1963–1972. https://doi.org/10.1177/13524585221099169

Marrie, R. A., Allegretta, M., Barcellos, L. F., Bebo, B., Calabresi, P. A., Correale, J., Davis, B., De Jager, P. L., Gasperi, C., Greenbaum, C., Helme, A., Hemmer, B., Kanellis, P., Kostich, W., Landsman, D., Lebrun-Frenay, C., Makhani, N., Munger, K. L., Okuda, D. T., … Tremlett, H. (2022). From the prodromal stage of multiple sclerosis to disease prevention. Nature Reviews Neurology, 18(9), 559–572. https://doi.org/10.1038/s41582-022-00686-x

Boorgu, D. S. S. K., Venkatesh, S., Lakhani, C. M., Walker, E., Aguerre, I. M., Riley, C., Patel, C. J., De Jager, P. L., & Xia, Z. (2022). The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis. Multiple Sclerosis and Related Disorders, 65, 103994. https://doi.org/10.1016/j.msard.2022.103994

Sorosina, M., Barizzone, N., Clarelli, F., Anand, S., Lupoli, S., Salvi, E., Mangano, E., Bordoni, R., Roostaei, T., Mascia, E., Zuccalà, M., Vecchio, D., Cavalla, P., Santoro, S., Ferrè, L., Zollo, A., Florio, L., Ragonese, P., … Martinelli Boneschi, F. (2022). A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility. Journal of Neurology, 269(8), 4510–4522. https://doi.org/10.1007/s00415-022-11109-8

Rotstein, D., Solomon, J. M., Sormani, M. P., Montalban, X., Ye, X. Y., Dababneh, D., Muccilli, A., & Shah, P. (2022). Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis. Neurology, 99(2). https://doi.org/10.1212/wnl.0000000000200549

Kever, A., Riley, C. S., & Leavitt, V. M. (2022). Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis. Multiple Sclerosis Journal, 28(8), 1311–1314. https://doi.org/10.1177/13524585211070496

Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177

Breneman, A. N., Eber, A. E., Haque, H., Levine, L., Askanase, A., Riley, C. S., Pomeranz, M. K., Hassan, D., Mancebo, S. E., Polin, M., Melamed, A., Bordone, L. A., Rosser, M., Gockley, A., & Gallitano, S. M. (2022). Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis. Journal of Lower Genital Tract Disease, 26(2), 189–191. https://doi.org/10.1097/lgt.0000000000000661

Kever, A., Walker, E. L. S., Riley, C. S., Heyman, R. A., Xia, Z., & Leavitt, V. M. (2022). Association of personality traits with physical function, cognition, and mood in multiple sclerosis. Multiple Sclerosis and Related Disorders, 59, 103648. https://doi.org/10.1016/j.msard.2022.103648

Kever, A., & Leavitt, V. M. (2021). Assessing diagnosis disclosure and concealment in multiple sclerosis: Development and initial validation of the DISCO-MS survey. Multiple Sclerosis Journal, 28(2), 247–256. https://doi.org/10.1177/13524585211037581

Buyukturkoglu, K., Vergara, C., Fuentealba, V., Tozlu, C., Dahan, J. B., Carroll, B. E., Kuceyeski, A., Riley, C. S., Sumowski, J. F., Oliva, C. G., Sitaram, R., Guevara, P., & Leavitt, V. M. (2021). Machine learning to investigate superficial white matter integrity in early multiple sclerosis. Journal of Neuroimaging, 32(1), 36–47. Portico. https://doi.org/10.1111/jon.12934

Roostaei, T., Klein, H.-U., Ma, Y., Felsky, D., Kivisäkk, P., Connor, S. M., Kroshilina, A., Yung, C., Kaskow, B. J., Shao, X., Rhead, B., Ordovás, J. M., Absher, D. M., Arnett, D. K., Liu, J., Patsopoulos, N., Barcellos, L. F., Weiner, H. L., & De Jager, P. L. (2021). Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27427-w

Lou, C., Sati, P., Absinta, M., Clark, K., Dworkin, J. D., Valcarcel, A. M., Schindler, M. K., Reich, D. S., Sweeney, E. M., & Shinohara, R. T. (2021). Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging. NeuroImage: Clinical, 32, 102796. https://doi.org/10.1016/j.nicl.2021.102796

Klineova, S., Harel, A., Straus Farber, R., DeAngelis, T., Zhang, Y., Hentz, R., Leung, T. M., Fong, K., Smith, T., Blanck, R., & Zhovtis-Ryerson, L. (2021). Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC). Multiple Sclerosis and Related Disorders, 55, 103153. https://doi.org/10.1016/j.msard.2021.103153